163 related articles for article (PubMed ID: 35018149)
1. Fixed 30 mCi (1110 MBq)
Pereira LSB; Riguetto CM; Neto AM; Tambascia MA; Ramos CD; Zantut-Wittmann DE
World J Nucl Med; 2021; 20(4):349-354. PubMed ID: 35018149
[TBL] [Abstract][Full Text] [Related]
2. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
[TBL] [Abstract][Full Text] [Related]
3. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
[TBL] [Abstract][Full Text] [Related]
4. Utility of outpatient fractionated radioiodine therapy for Graves disease involving a large goiter measuring more than 100 mL in volume.
Mizokami T; Hamada K; Maruta T; Higashi K; Tajiri J
Endocr J; 2021 Sep; 68(9):1117-1125. PubMed ID: 33980774
[TBL] [Abstract][Full Text] [Related]
5. Radioiodine therapy for multinodular toxic goiter.
Nygaard B; Hegedüs L; Ulriksen P; Nielsen KG; Hansen JM
Arch Intern Med; 1999 Jun; 159(12):1364-8. PubMed ID: 10386513
[TBL] [Abstract][Full Text] [Related]
6. Fixed 30 mCi 131I-iodine therapy without recombinant human thyroid-stimulating hormone stimulation as an attractive therapeutic alternative in nontoxic nodular goiter.
Riguetto CM; Miguel VP; Pavin EJ; Amorim BJ; Ramos CD; Zantut-Wittmann DE
Nucl Med Commun; 2020 Aug; 41(8):727-732. PubMed ID: 32427701
[TBL] [Abstract][Full Text] [Related]
7. The incidence of recurrence and hypothyroidism after radioiodine treatment in patients with hyperthyroidism in Trakya, a mild iodine deficiency area, during the period 1991-2003.
Ustun F; Yuksel M; Durmus-Altun G; Kaya M; Cermik TF; Sarikaya A; Berkarda S
Ann Nucl Med; 2005 Dec; 19(8):737-42. PubMed ID: 16445003
[TBL] [Abstract][Full Text] [Related]
8. Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules.
Nygaard B; Hegedüs L; Nielsen KG; Ulriksen P; Hansen JM
Clin Endocrinol (Oxf); 1999 Feb; 50(2):197-202. PubMed ID: 10396362
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Hypothyroidism Following Empirical Dose Radioiodine in Toxic Thyroid Nodules: Real-Life Experience.
Demir BK; Karakilic E; Saygili ES; Araci N; Ozdemir S
Endocr Pract; 2022 Aug; 28(8):749-753. PubMed ID: 35537668
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Outcomes of Radioiodine Therapy for Juvenile Graves Disease with Emphasis on Subsequently Detected Thyroid Nodules: A Single Institution Experience from Japan.
Mizokami T; Hamada K; Maruta T; Higashi K; Tajiri J
Endocr Pract; 2020 Jul; 26(7):729-737. PubMed ID: 33471641
[TBL] [Abstract][Full Text] [Related]
11. Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.
Mojsak MN; Abdelrazek S; Szumowski P; Rogowski F; Sykała M; Kostecki J; Kociura-Sawicka A; Jurgilewicz D; Myśliwiec J
Nucl Med Rev Cent East Eur; 2016; 19(1):3-11. PubMed ID: 26841373
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Radioiodine Treatment for Toxic Nodular Goiter.
Şakı H; Cengiz A; Yürekli Y
Mol Imaging Radionucl Ther; 2015 Oct; 24(3):100-4. PubMed ID: 27529884
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Follow-up of Patients With Autonomous Thyroid Nodules Treated With Radioiodine.
Moroto D; Torquato-Vieira ICO; Fiorin LB; Camacho CP; Castiglioni MLV; Maciel RMB; Furlanetto RP; Matsumura LK; Janovsky CCPS; Lindsey SC; Martins JRM
Clin Nucl Med; 2024 Jun; 49(6):529-535. PubMed ID: 38619976
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of standard ten millicurie dose of radio-iodine in management of autonomously functioning toxic thyroid nodules.
Sharma R; Bhatnagar A; Mondal A; Kashyap R; Khanna CM
J Assoc Physicians India; 1995 Mar; 43(3):167-9, 172. PubMed ID: 11256900
[TBL] [Abstract][Full Text] [Related]
16. [Predictors of the efficacy of radioiodine therapy of Graves' disease in children and adolescents].
Rumyantsev PO; Saenko VA; Dzeytova DS; Trukhin AA; Sheremeta MS; Slashchuk KY; Degtyarev MV; Serzhenko SS; Yasuchenia VS; Zakharova SM; Sirota YI
Probl Endokrinol (Mosk); 2020 Oct; 66(4):68-76. PubMed ID: 33351361
[TBL] [Abstract][Full Text] [Related]
17. Radioiodine treatment of Plummer and multinodular toxic and nontoxic goiter disease by the first approximation dosimetry method.
Zingrillo M; Urbano N; Suriano V; Modoni S
Cancer Biother Radiopharm; 2007 Apr; 22(2):256-60. PubMed ID: 17600473
[TBL] [Abstract][Full Text] [Related]
18. [The treatment of multinodular large non-toxic goiter using repeated doses of radioiodine (preliminary report)].
Pisarek M; Baczyk M; Gryczyńska M; Sowiński J
Endokrynol Pol; 2007; 58(1):18-26. PubMed ID: 17354201
[TBL] [Abstract][Full Text] [Related]
19. Five-year follow-up of percutaneous ethanol injection for the treatment of hyperfunctioning thyroid nodules: a study of 117 patients.
Monzani F; Caraccio N; Goletti O; Lippolis PV; Casolaro A; Del Guerra P; Cavina E; Miccoli P
Clin Endocrinol (Oxf); 1997 Jan; 46(1):9-15. PubMed ID: 9059552
[TBL] [Abstract][Full Text] [Related]
20. The influence of thyroid hormone medication on intra-therapeutic half-life of
Happel C; Kranert WT; Bockisch B; Sabet A; Grünwald F; Groener D
Sci Rep; 2022 Aug; 12(1):13925. PubMed ID: 35978004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
